Diagnostic Technologies: Page 3

Machine-learning model predicts lung and liver cancer through genome sequence changes
By LabPulse.com staff writers
Researchers have developed a machine-learning approach that may potentially predict early-stage lung or liver cancer by detecting repetitive sequences in the genome.
March 15, 2024
Artificial Intelligence Lung Color Social
NGeneBio, Genolution to collaborate on automated NGS system
By LabPulse.com staff writers
Precision diagnostics company NGeneBio and molecular diagnostics firm Genolution have signed a memorandum of understanding to develop and launch an automated next-generation sequencing (NGS) system.
March 14, 2024
Business Handshake Intelligence Social
Zephyr AI closes $111M series A funding round
By LabPulse.com staff writers
Biotech startup Zephyr AI announced on Wednesday that it successfully closed a $111 million series A funding round.
March 13, 2024
Artificial Intelligence Drug Design Funding Social
Metabolon releases integrated bioinformatics platform
By Matt Limb
Metabolon has launched an integrated bioinformatics platform to aid metabolomics analysis in life sciences research.
March 12, 2024
Laboratory Software Social
Predictive AI model might aid early-stage NSCLC planning
By Liz Carey
The deep-learning AI model identified features that were not readily discernable to a trained pathologist.
March 12, 2024
Cancer Lung 3 D Black Social
Study: AI assists discovery of prostate cancer subtypes
By Matt Limb
Prostate tumors have been found to evolve along multiple pathways, leading to two distinct disease types with “pivotal” implications for diagnosis and treatment, say scientists.
March 8, 2024
3 D Prostate Cancer Viral Social
Gene-based technique shows potential for rapid diagnostics
By LabPulse.com staff writers
Biomedical engineers have developed a new gene-based approach which can be used on test strips for rapid, on-the-spot disease detection with accuracy comparable to that of lab-based polymerase chain reaction (PCR) tests.
March 7, 2024
Sequencing Virus Social
Ibex, PathPresenter ink partnership
By LabPulse.com staff writers
Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to enable wider use of AI-enabled digital pathology for their joint customers.
March 6, 2024
Hands Shaking2 Social
FDA LDT oversight battle: Are we close?
By Liz Carey
New directions in laboratory developed test (LDT) regulation appeared closer to final rule-making with the March 1 Office of Management and Budget (OMB) acceptance of the LDT final rule, pending regulatory review: a flurry of final rule-making thoughts.
March 6, 2024
Omb Final Rule Laboratory Developed Tests March124
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Money Bag Grant Award Social
Reversible, multiplex CRISPR system enhances efficacy of CAR-T cell therapy
By Nick Paul Taylor
A CRISPR system that uses Cas13d to make reversible changes to the expression of multiple genes could overcome limitations that are holding back CAR-T cell therapies, a paper published in Cell suggests.
February 28, 2024
Licensed under Creative Commons
Alamar Biosciences raises $100M in series C financing round
By LabPulse.com staff writers
Precision proteomics company Alamar Biosciences has raised $100 million in an oversubscribed series C financing round, with a second close of an additional $28 million anticipated within the next 30 days.
February 27, 2024
Money Hundred Bills Social
Previous Page
Page 3 of 310
Next Page